Примечания

1

Kassebaum, N. J., M. Arora, R. M. Barber, J. Brown, & A. Roy. 2016. “Global, Regional, and National Disability-Adjusted Life-Years (D.A.L.Y.S) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE), 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015.” The Lancet 388(10053): 1603–1658.

2

Anxiety and Depression Association of America. n.d. “Anxiety Disorders—Facts & Statistics.” Accessed November 13, 2022. https://adaa.org/understanding-anxiety/facts-statistics.

3

Anxiety and Depression Association of America. “Anxiety Disorders – Facts & Statistics.”

4

Anxiety and Depression Association of America. “Anxiety Disorders – Facts & Statistics.”

5

Dibdin, E. 2021. “9 Unusual Anxiety Symptoms You Might Not Know About,” Psych Central, July 6, 2021. https://psychcentral.com/anxiety/unusual-anxiety-symptoms-you-might-not-know-about.

6

Wallis, K. A., M. Donald, & J. Moncrieff. 2021. “Antidepressant Prescribing in General Practice: A Call to Action.” Australian Journal of General Practice 50(12): 954–956.

7

Takayanagi, Y., A. P. Spira, O. J. Bienvenu, R. S. Hock, M. C. Carras, W. W. Eaton, et al. 2014. “Antidepressant Use and Lifetime History of Mental Disorders in a Community Sample: Results from the Baltimore Epidemiologic Catchment Area Study.” The Journal of Clinical Psychiatry 76(1): 40–44.

8

Kirsch, Irving. 2019. “Placebo Effect in the Treatment of Depression and Anxiety.” Frontiers in Psychiatry 10: 407.

9

Wallis, Donald, & Moncrieff. “Antidepressant Prescribing in General Practice.”

10

Longo, L. P., & B. Johnson. 2000. “Addiction: Part I. Benzodiazepines—Side Effects, Abuse Risk, and Alternatives.” American Family Physician 61(7): 2121.

11

McLaughlin, M. n.d. “Anxiety and Depression: Why Don’t We Want to Take Medication?” Heartgrove Behavioral Health System. Accessed November 13, 2022. https://www.hartgrovehospital.com/anxiety-depression-dont-want-take-medication.

12

Chekroud, A. M., D. Foster, A. B. Zheutlin, D. M. Gerhard, B. Roy, N. Koutsouleris, & J. H. Krystal. 2018. “Predicting Barriers to Treatment for Depression in a U.S. National Sample: A Cross-Sectional, Proof-of-Concept Study.” Psychiatric Services 69(8): 927–934.

13

Levy, H. C., E. M. O’Bryan, & D. F. Tolin. 2021. “A Meta-Analysis of Relapse Rates in Cognitive-Behavioral Therapy for Anxiety Disorders.” Journal of Anxiety Disorders 81: 102407.

14

Levy, H. C., K. T. Stevens, & D. F. Tolin. 2022. “Research Review: A Meta—Analysis of Relapse Rates in Cognitive Behavioral Therapy for Anxiety and Related Disorders in Youth.” Journal of Child Psychology and Psychiatry 63(3): 252–260.

15

Ali, S., L. Rhodes, O. Moreea, D. McMillan, S. Gilbody, C. Leach, et al. 2017. “How Durable Is the Effect of Low-Intensity C.B.T. for Depression and Anxiety? Remission and Relapse in a Longitudinal Cohort Study.” Behaviour Research and Therapy 94: 1–8.

16

Otto, M. W., R. K. McHugh, & K. M. Kantak. 2010. “Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.” Clinical Psychology: Science and Practice 17(2): 91 – 103.

17

Lynch, D., K. R. Laws, & P. J. McKenna. 2010. “Cognitive Behavioural Therapy for Major Psychiatric Disorder: Does It Really Work? A Meta-Analytical Review of Well Controlled Trials.” Psychological Medicine 40(1): 9 – 24.

18

Levy, O’Bryan, & Tolin. “A Meta-Analysis of Relapse Rates in Cognitive-Behavioral Therapy for Anxiety Disorders.”

19

Rashid, T., & M. K. A-H. Baddar. 2019. “Positive Psychotherapy: Clinical and Cross Cultural Applications of Positive Psychology.” In Positive Psychology in the Middle East/North Africa, edited by L. Lambert & N. Pasha-Zaidi. Springer Nature Switzerland.

20

Bahadur, N. 2020. “What Is Resilience, and Can It Help Us Bounce Back from This?” Self, May 28, 2020. https://www.self.com/story/what-is-resilience.

21

Nabizadeh, R., N. Ensanimehr, & S. Ehsani. 2019. “Investigating the Impact of the Achievement Motivation on Psychological Well-Being by Investigating the Mediating Role of Ego Strength and Psychological Capacity.” Razi Journal of Medical Sciences 26(1): 68–77.

22

Luthans, F., K. W. Luthans, & B. C. Luthans. 2004. “Positive Psychological Capital: Beyond Human and Social Capital.” Business Horizons 47(1): 45–50.

23

Luthans, F., & C. M. Youssef-Morgan. 2017. “Psychological Capital: An Evidence-Based Positive Approach.” Annual Review of Organizational Psychology and Organizational Behavior 4: 339–366.

24

Luthans, Luthans, & Luthans. “Positive Psychological Capital.”

25

Belil, F., F. Alhani, A. Ebadi, & A. Kazemnejad. 2018. “Self-Efficacy of People with Chronic Conditions: A Qualitative Directed Content Analysis.” Journal of Clinical Medicine 7(11): 411.

Загрузка...